Haleos Labs Limited
Haleos Labs Limited | 540679
Share Price Chart - Haleos Labs Limited
Stock Performance
Ratios
About Company
- SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006
- The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector
- The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w
- 2016 and subsequently got converted into a Public Limited w
- The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates
- The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL
- What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments
- SMS Group was given the export house status in the year 1997-98
- Having three multi product facilities in operation and a research centre, the Company executed contract manufacturing and research assignment for global customer base
- The Scheme of Arrangement between SMS Pharmaceuticals Limited with the Company was implemented in 2016-17
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *

Top Gainers
Frequently Asked Questions
What is Share Price of Haleos Labs Limited?
The current share price of Haleos Labs Limited (Haleos Labs Limited) is ₹1596.60. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Haleos Labs Limited?
The Price-to-Earnings (P/E) ratio of Haleos Labs Limited is 1596.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Haleos Labs Limited?
Haleos Labs Limited has a 52-week high of ₹1774.00 and a 52-week low of ₹1067.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Haleos Labs Limited?
Haleos Labs Limited offers a dividend yield of 0.10%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Haleos Labs Limited?
The Earnings Per Share (EPS) of Haleos Labs Limited is ₹57.26. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Haleos Labs Limited?
Haleos Labs Limited has a Return on Equity (ROE) of 11.45%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
